Key result
Hepatic lipase exerts predominantly antiatherogenic effects in lipoprotein metabolism, offering a potential therapeutic target in CVD.
Answers are grounded in this paper and cite their sources.
This review highlights the predominantly antiatherogenic functions of hepatic lipase in lipoprotein metabolism and its potential as a therapeutic target for atherosclerotic cardiovascular disease.
Despite a growing therapeutic arsenal, atherosclerotic cardiovascular disease remains the major cause of mortality worldwide. Hepatic lipase, encoded by the gene LIPC , is a protein that has recently regained interest in this context. In this review, we provide a comprehensive overview of the versatile roles of hepatic lipase in lipoprotein metabolism, with a focus on the recently discovered LIPC -E97G variant. Specifically, we discuss the roles of hepatic lipase in the metabolism of high-density lipoproteins and apoB-containing lipoproteins, as elucidated through in vitro, in vivo, and genetic studies. We also explore the complex interplay between the antiatherogenic and proatherogenic effects of hepatic lipase, highlighting a predominance of antiatherogenic functions for hepatic lipase. Lastly, we briefly discuss how the knowledge on the function of hepatic lipase can potentially be harnessed for the treatment of atherosclerotic cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Dijk et al. (2025) conducted a review in Atherosclerotic cardiovascular disease. Hepatic lipase was evaluated. Hepatic lipase plays versatile roles in lipoprotein metabolism, demonstrating a predominance of antiatherogenic functions that could potentially be harnessed for treating cardiovascular disease.
Synapse has enriched 10 related papers. Consider them for comparative context: